|
FY2020
12 months to May 31, 2020
|
|
|---|---|
| Cannabis revenue | |
| Distribution revenue | |
| Insurance recovery | |
| Excise taxes | |
| Net revenue | |
| Production costs | |
| Cost of cannabis purchased | |
| Cost of goods purchased | |
| Gross profit before fair value adjustments | |
| Fair value adjustment on sale of inventory | |
| Fair value adjustment on growth of biological assets | |
| Gross profit | |
| Operating expenses: | |
| General and administrative | |
| Share-based compensation | |
| Amortization | |
| Selling | |
| Marketing and promotion | |
| Research and development | |
| Impairment | |
| Transaction costs | |
| Total Operating expenses | |
| Operating loss | |
| Finance income (expense), net | |
| Non-operating income, net | |
| Loss before income taxes | |
| Income taxes (recovery) | |
| Net loss | |
| Other comprehensive loss | |
| Other comprehensive loss | |
| Comprehensive loss | |
| Weighted average number of common shares—basic | |
| Weighted average number of common shares—diluted | |
| Loss per share—basic | |
| Loss per share—diluted | |
| Total comprehensive income (loss) attributable to: | |
| Shareholders of Aphria Inc. | |
| Non-controlling interests |
Loading...
